Find clinical trials for Lymphoma in Ann Arbor, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Ann Arbor, MI, USA:
patients diagnosed with advanced Relapsed/Refractory non-Hodgkin's lymphoma to determine if ARV-393 may be a possible treatment option.ARV-3...
Phase 1
Detroit, Michigan, United States and 13 other locations
and ibrutinib in patients with previously treated mantle cell lymphoma to evaluate the efficacy of this combination, with the primary object...
Phase 2
Ypsilanti, Michigan, United States and 8 other locations
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....
Phase 1
Ann Arbor, Michigan, United States and 7 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Detroit, Michigan, United States and 66 other locations
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Ann Arbor, Michigan, United States and 31 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Ann Arbor, Michigan, United States and 59 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Ypsilanti, Michigan, United States and 71 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Ann Arbor, Michigan, United States and 215 other locations
with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:* To improve the event-free su...
Phase 2, Phase 3
Detroit, Michigan, United States and 7 other locations
This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.
Phase 2
Ann Arbor, Michigan, United States and 29 other locations
Clinical trials
Research sites
Resources
Legal